Cronos (CRON) Total Non-Current Liabilities (2016 - 2026)

Cronos (CRON) recorded quarterly Total Non-Current Liabilities of $47.5 million in Q1 2026, down 11.04% quarter-over-quarter from $53.4 million in Q4 2025, and up 23.65% on a YoY basis from $38.5 million in Q1 2025.

Cronos (CRON) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends

Cronos' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $47.5 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 23.65% year-over-year to $47.5 million; the TTM figure through Mar 2026 stood at $47.5 million (up 23.65% YoY), while the FY2025 annual figure was $53.4 million, changed N/A from the prior year.
  • Total Non-Current Liabilities was $47.5 million for Q1 2026 at Cronos, down from $53.4 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $73.8 million in Q4 2022 to a low of $30.7 million in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $45.2 million across 5 years, with a median of $45.6 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities slumped 85.45% in 2022, then jumped 59.5% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $73.8 million in 2022, then declined by 12.15% to $64.8 million in 2023, then retreated by 20.42% to $51.6 million in 2024, then gained by 3.62% to $53.4 million in 2025, then declined by 11.04% to $47.5 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $47.5 million (Q1 2026), $53.4 million (Q4 2025), and $45.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Cronos 1.06 Bn 284.85 Mn 19.15 Mn 47.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.55 Mn
Dec 31, 2025 53.45 Mn
Sep 30, 2025 45.66 Mn
Jun 30, 2025 44.34 Mn
Mar 31, 2025 38.45 Mn
Sep 30, 2024 51.58 Mn
Jun 30, 2024 34.12 Mn
Mar 31, 2024 34.72 Mn
Dec 31, 2023 64.81 Mn
Sep 30, 2023 32.34 Mn
Jun 30, 2023 30.65 Mn
Mar 31, 2023 33.18 Mn
Dec 31, 2022 73.78 Mn
Sep 30, 2022 46.23 Mn
Jun 30, 2022 47.25 Mn
Mar 31, 2022 45.53 Mn
Dec 31, 2021 81.59 Mn
Sep 30, 2021 44.25 Mn
Jun 30, 2021 208.70 Mn
Mar 31, 2021 313.00 Mn